Neurolentech signs technology access partnership with Kaerus Bioscience to advance neurodevelopmental disorder research
Kaerus Bioscience will access Neurolentech’s NDD Drug Discovery Platform to support development of its preclinical asset pipeline for numerous genetic syndromes.
Guardtech Group strengthen sales team with addition of new GMP Commercial Manager
Cleanroom construction experts set to elevate full-package offering with recruitment of experienced Pharma specialist John Edwards
Sphere Fluidics appoints Edward Rayner as Non-Executive Director
Ed Rayner joins Sphere Fluidics as new board member to strengthen the Company’s strategic vision and ambition for commercial growth.
Navigating payer challenges in rare disease
Clinical and economic evidence generation across rare diseases is challenging due to intrinsic disease characteristics, misalignment on treatment costs, and inadequate traditional evaluation frameworks.
Zyme Communications expands UK head office with new facilities at Cambridge Innovation Park
Investment in new headquarters forms part of ongoing company growth plans and supports Zyme’s continued success, following client base and team expansion.
Sphere Fluidics appoints Edward Rayner as Non-Executive Director
Ed Rayner joins Sphere Fluidics as new board member to strengthen the Company’s strategic vision and ambition for commercial growth.
ELRIG UK and SRG announce partnership to advance life science professionals in drug discovery
Partnership endorses mission to facilitate career progression and support life science industry growth.
Guardtech land Medilink Midlands Business Awards Innovation nomination with CleanCube
The Group’s unique portable container laboratories will be up for the gong at Medilink’s Athena Leicester showpiece next month
Onwards and upwards for expression edits
The Epicentre, Haverhill spoke to Chief Operating Officer Dr Rebecca Godfrey about how ExpresionEdits was started, what it is currently working on and how its experience at The EpiCentre has helped it grow the business and move on to the next phase of its expansion.
Bio-Rad announces collaboration agreement with Oncocyte to commercialize transplant monitoring with Droplet Digital PCR
Collaboration Aims to Provide Researchers Cutting-Edge Tools to Enable Transformational Monitoring of Key Biomarkers in Solid Tissue Transplants
Metrion Biosciences enhances High Throughput Screening services with access to Enamine compound libraries
Access to compound collection enables greater flexibility and efficiencies in screening and target identification
Introducing Timestrip neo Multi
Timestrip Introduces World’s First Multiple Use Temperature Indicator. Timestrip has introduced what is believed to be the first multiple-use temperature indicator of its kind available.
Preci and Biopredic International partner for higher performance of suspended pooled hepatocytes with extended longevity and large-scale availability
License agreement extends access to culture-stable pooled hepatocyte cell models with increased longevity for use in DMPK and ADME studies
Young heroes from The Regis School help transform children’s health research
In collaboration with our partners at leading mental health charity Anna Freud, D-CYPHR held a learning event at the West Sussex secondary school, listening to pupils’ ideas around children’s rights to good health and highlighting different ways they can make a positive impact.
COVID-19 BioResource participants in new study identifying key trigger of long COVID
Volunteer data from our COVID-19 BioResource has been used in a new study, published by Nature Immunology, which discovered that problems with iron levels in the blood and the body’s ability to regulate this important nutrient as a result of SARS-CoV-2 infection could be a key trigger for long COVID.
Have you heard about Carers Leave?
From 6 April 2024 all unpaid carers are entitled to up to a week's unpaid leave per year to look after someone with a disability or long-term illness. But don't panic! We are here to help :-)
Understanding and managing Interstitial Lung Disease
Interstitial lung disease (ILD) is an umbrella term used to describe a group of highly variable restrictive lung diseases, which are characterised by inflammation and pulmonary fibrosis (scarring of the lungs).
Bio-Rad and Allegheny Health Network Cancer Institute collaborate to advance personalised monitoring of solid tumor cancers with Droplet Digital PCR
Collaboration aims to grow clinical evidence supporting the use of Bio-Rad’s ddPCR™ technology for molecular residual disease monitoring of patients across a range of solid tumor types.
Guardtech Group ready to spring into action with another string of exhibitions
Suffolk-based cleanroom construction specialists line up four massive shows in April, May and June
GLAD Study opens recruitment for participants without history of mental health condition
The Genetic Links to Anxiety and Depression (GLAD) Study, part of our Mental Health BioResource, is thrilled to announce the launch of a recruitment drive for individuals without a history of anxiety and depression. In a world where millions are affected by mental health struggles like anxiety and depression, it is crucial to understand more about the complex web of genetic and environmental…
Sookio launches podcast, Communication Untangled
Join host Sue Keogh and guests from the worlds of design, communications, and behavioural psychology for Communication Untangled – a new podcast exploring the many facets of communication that influence our behaviour, but often go unnoticed.
Bio-Rad launches first Ultrasensitive Multiplexed Digital PCR Assay for breast cancer mutation detection in clinical research
Highly Sensitive and Multiplexed Assay for the Detection, Discrimination, and Quantification of Key Mutations in ESR1 Gene for Breast Cancer, Developed for Bio-Rad’s QX600™ Droplet Digital™ PCR System
Digital Biomarkers: capturing real-world patient journeys to advance care
Digital biomarkers hold great promise in advancing patient care through improved patient monitoring.
Advanced Threat Group (ATG) & CyberScale Strategic Alliance
On 1st April 2024 CyberScale and Advanced Threat Group (ATG) formally recognised a strategic alliance aimed at providing their clients with an optimal combination of strategic advice and technical support around Cyber & Information Security.